SCHEMBL8880983

SCHEMBL8880983

O=C1CC=CC2=C1c1cccc(C(F)(F)F)c1SN=C2

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PSMB8 P28062 1/20 0.31
▸ CES1 P23141 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9007282 0.88 — —
SCHEMBL8880391 0.84 — —
SCHEMBL8878976 0.80 NOTUM (0.33) PSMB8CES1
SCHEMBL8880832 0.78 — —
SCHEMBL8880019 0.76 KDM4E (0.32) —
SCHEMBL8877757 0.75 CES1 (0.30) CES1
SCHEMBL8879370 0.74 TDP2 (0.32) —
SCHEMBL8879548 0.74 — —
SCHEMBL9007325 0.71 HSD11B1 (0.30) —
SCHEMBL9007416 0.71 HDAC8 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607929-A Antiviral dibenzothiazepinone derivatives GLAXO WELLCOME INC. (US) 1997-03-04 — — US claimed
EP-0583288-A1 ANTIVIZAL DIBENZOTHIAZEPINONE DERIVATIVES THE WELLCOME FOUNDATION LIMITED (GB) 1994-02-23 — — EP claimed
WO-1992019277-A1 ANTIVIRAL DIBENZOTHIAZEPINONE DERIVATIVES THE WELLCOME FOUNDATION LIMITED (GB) 1992-11-12 — — WO claimed
US-5607929-A Antiviral dibenzothiazepinone derivatives GLAXO WELLCOME INC. (US) 1997-03-04 — — US disclosed
EP-0583288-A1 ANTIVIZAL DIBENZOTHIAZEPINONE DERIVATIVES THE WELLCOME FOUNDATION LIMITED (GB) 1994-02-23 — — EP disclosed
WO-1992019277-A1 ANTIVIRAL DIBENZOTHIAZEPINONE DERIVATIVES THE WELLCOME FOUNDATION LIMITED (GB) 1992-11-12 — — WO disclosed
Send feedback